09/12/2024 6:31 AM | Biogen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/05/2024 5:00 AM | Biogen (Issuer) Singhal Priya (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/03/2024 12:00 PM | Biogen (Subject) Singhal Priya (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/16/2024 5:40 PM | Biogen (Filed by) SANGAMO THERAPEUTICS, INC (Subject)
| Form SC 13G/A | |
08/01/2024 5:55 AM | Biogen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/25/2024 4:01 PM | Biogen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/25/2024 4:06 PM | Biogen (Issuer) DORSA CAROLINE (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
06/25/2024 4:13 PM | Biogen (Issuer) Freire Maria C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 4:14 PM | Biogen (Issuer) HAWKINS WILLIAM A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 4:15 PM | Biogen (Issuer) Patolawala Monish D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 4:16 PM | Biogen (Issuer) LANGER SUSAN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 4:18 PM | Biogen (Issuer) Rowinsky Eric K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 4:19 PM | Biogen (Issuer) Mantas Jesus B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 4:20 PM | Biogen (Issuer) SHERWIN STEPHEN A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 4:08 PM | Biogen (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/03/2024 7:00 PM | Biogen (Issuer) Keeney Adam (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/26/2024 4:15 PM | Biogen (Filer)
| Form ARS | |
04/24/2024 3:15 PM | Biogen (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/24/2024 6:02 AM | Biogen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/12/2024 4:01 PM | Biogen (Filer)
| Form PRE 14A | |
04/03/2024 7:24 PM | Biogen (Issuer) Singhal Priya (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 7:11 PM | Biogen (Issuer) Murphy Nicole (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/02/2024 9:08 AM | Biogen (Subject) Singhal Priya (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024 6:54 PM | Biogen (Issuer) Singhal Priya (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/22/2024 9:12 AM | Biogen (Subject) Singhal Priya (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024 8:31 PM | Biogen (Issuer) Kramer Robin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 8:33 PM | Biogen (Issuer) Izzar Rachid (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 8:36 PM | Biogen (Issuer) Gregory Ginger (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 8:39 PM | ALEXANDER SUSAN H (Reporting) Biogen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 8:27 PM | Biogen (Issuer) Singhal Priya (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 8:28 PM | Biogen (Issuer) Murphy Nicole (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 8:29 PM | Biogen (Issuer) MCDONNELL MICHAEL R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/21/2024 9:24 AM | Biogen (Subject) Singhal Priya (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024 8:13 PM | Biogen (Issuer) Rowinsky Eric K (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 4:56 PM | ALEXANDER SUSAN H (Reporting) Biogen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 5:00 PM | Biogen (Issuer) Izzar Rachid (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 5:01 PM | Biogen (Issuer) Kramer Robin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 5:03 PM | Biogen (Issuer) MCDONNELL MICHAEL R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 5:04 PM | Biogen (Issuer) Murphy Nicole (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 5:06 PM | Biogen (Issuer) Singhal Priya (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/13/2024 5:14 PM | Biogen (Issuer) Gregory Ginger (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
My big AI project… (Ad) On Wednesday, September 25, I’m putting on my first crypto event in two years to unveil: the Perceptron.
This is my AI project that I first conceived of shortly after I recommended Nvidia back in 2016. Just click here to register. |
02/13/2024 6:07 AM | Biogen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/12/2024 6:07 PM | Biogen (Filed by) Denali Therapeutics Inc. (Subject)
| Form SC 13G/A | |
02/12/2024 6:11 PM | Biogen (Filed by) SANGAMO THERAPEUTICS, INC (Subject)
| Form SC 13G/A | |
02/12/2024 10:21 AM | Biogen (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
02/12/2024 10:10 AM | Biogen (Subject) Singhal Priya (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024 9:50 AM | Biogen (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
02/09/2024 7:11 PM | Biogen (Issuer) Izzar Rachid (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 7:12 PM | Biogen (Issuer) Grogan Jane (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 7:14 PM | Biogen (Issuer) Gregory Ginger (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 7:16 PM | ALEXANDER SUSAN H (Reporting) Biogen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 6:56 PM | Biogen (Issuer) Viehbacher Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 6:59 PM | Biogen (Issuer) Singhal Priya (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 7:01 PM | Biogen (Issuer) Murphy Nicole (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 7:03 PM | Biogen (Issuer) MCDONNELL MICHAEL R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 7:06 PM | Biogen (Issuer) Kramer Robin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 7:08 PM | Biogen (Issuer) Keeney Adam (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2024 5:38 PM | Biogen (Issuer) Singhal Priya (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 9:44 AM | Biogen (Subject) Singhal Priya (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2024 4:34 PM | Biogen (Issuer) MCDONNELL MICHAEL R (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 4:35 PM | Biogen (Issuer) Murphy Nicole (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 4:36 PM | Biogen (Issuer) Singhal Priya (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 4:27 PM | ALEXANDER SUSAN H (Reporting) Biogen (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 4:30 PM | Biogen (Issuer) Gregory Ginger (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 4:31 PM | Biogen (Issuer) Izzar Rachid (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2024 4:33 PM | Biogen (Issuer) Kramer Robin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/09/2024 4:52 PM | Biogen (Issuer) Patolawala Monish D (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/12/2023 4:02 PM | Biogen (Issuer) Kramer Robin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 3:36 PM | Biogen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/11/2023 9:06 AM | Biogen (Subject) Singhal Priya (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/08/2023 6:02 AM | Biogen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/12/2023 4:15 PM | Biogen (Issuer) Grogan Jane (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
09/28/2023 4:25 PM | Biogen (Filer)
| Form 8-K/A | |
09/28/2023 4:30 PM | Biogen (Reporting) Biogen MA Inc. (Reporting) SANGAMO THERAPEUTICS, INC (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/28/2023 3:38 PM | Biogen (Filed by) REATA PHARMACEUTICALS INC (Subject)
| Form SC 13D/A | |
09/26/2023 4:25 PM | Biogen (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |